Recent Finacing
Recent Raise
TPP develops preclinical drugs by sourcing university and research-institute programs, advancing work in inventor labs or CROs for neurology, immunology/inflammation, and niche oncology, then licensing or spinning out.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor